Try our Advanced Search for more refined results
Intellectual Property
-
February 11, 2026
7th Circ. Mulls Expiration Date Of Teva, Eli Lilly Patent Deal
Seventh Circuit judges Wednesday pressed counsel for Teva Pharmaceuticals USA Inc. to address how long a settlement under which Eli Lilly & Co. agreed not to block the approval and marketing of Teva's generic version of its osteoporosis drug Forteo could reasonably remain in effect, given Teva's drug wasn't ready for market until years after the underlying patent dispute.
-
February 11, 2026
Shkreli Can't Add Wu-Tang Members To Fight With Crypto Co.
"Pharma Bro" Martin Shkreli can't drag two members of the Wu-Tang Clan hip-hop group into a suit brought by a crypto firm that claims Shkreli improperly retained copies of an album that it bought the rights to, a New York federal judge ruled on Wednesday.
-
February 11, 2026
MrBeast, Ex-IT Worker Near Deal In Trade Secret Theft Dispute
YouTube star MrBeast's media company has told a North Carolina federal judge it has reached a settlement in principle to resolve its lawsuit accusing a former IT contractor of downloading thousands of confidential company documents ahead of his firing and leaving behind hidden cameras throughout the company's offices.
-
February 11, 2026
AI Cos. Would Have To Disclose Training Under Bipartisan Bill
A bipartisan bill introduced in the U.S. Senate would require technology companies to disclose copyrighted works that they use to train generative artificial intelligence models with the U.S. Copyright Office.
-
February 11, 2026
Apple Keeps PTAB Win Over Fintiv Patent Claims At Fed. Circ.
The Federal Circuit on Wednesday upheld Apple's Patent Trial and Appeal Board win in its challenge to claims in a patent issued to the defunct Austin, Texas-based mobile payment startup that would become Fintiv.
-
February 11, 2026
Pegasystems Settles Mass. Shareholder Actions For $7M
Pegasystems has agreed to pay $7 million to settle three shareholder derivative suits in Massachusetts state and federal courts alleging the software company's top officials sat on details of a 2020 trade secrets suit that led to a now-overturned $2 billion verdict.
-
February 11, 2026
Bankruptcy Court Asked To Keep Nicklaus Biopic Deal Intact
A film production company has urged a Delaware bankruptcy court not to allow any successful bidder for brand licensing rights of Jack Nicklaus to disturb a biopic screenplay agreement involving an affiliate of the insolvent business bearing the golf legend's name, saying the firm's role is commercially critical.
-
February 11, 2026
Judge Tosses Patent Suit Over Decentralized Exchange Tech
A New York federal judge has thrown out a lawsuit accusing the companies behind Uniswap of infringing patents for smart contract technology used in decentralized exchanges, finding the patent claims didn't pass the U.S. Supreme Court's Alice test.
-
February 11, 2026
Intellectual Property Group Of The Year: Baker Botts
Attorneys in Baker Botts LLP's intellectual property practice successfully resolved a patent infringement case against Ericsson after wiping out a monster verdict against the company and fended off a decade-long licensing case against MasterCard, earning the firm a spot among the 2025 Law360 Intellectual Property Groups of the Year.
-
February 11, 2026
ZTE Escapes Samsung's Patent Licensing Case For Now
A California federal court has found that ZTE lacks sufficient connections to the U.S. for the court to have jurisdiction over claims from Samsung that the China-based technology company refuses to license its standard essential patents on fair terms.
-
February 11, 2026
Insurer Must Defend Real Estate Firm Against Copyright Suit
An insurer must defend a real estate company against claims that it infringed an architect's copyright in marketing materials for a newly-built home, a Massachusetts federal court ruled, finding that an exclusion for misappropriated property does not apply to bar coverage.
-
February 10, 2026
Adobe Faces Another Suit Over Alleged AI Training Piracy
Adobe Inc. was hit with another proposed class action in California federal court, accusing the software giant of surreptitiously using hundreds of thousands of copyrighted books in the "notorious" RedPajama and Common Crawl datasets to train its SlimLM artificial intelligence models without authors' consent.
-
February 10, 2026
Valve's Trial Against Accused Patent Troll Begins In Seattle
Valve Corp. told a Seattle federal jury Tuesday that inventor Leigh Rothschild and his intellectual property firms spent years "harassing" the video game company over patents it was already licensed to use in pursuit of a bigger payout, pressing play on a trial that will test Washington's Patent Troll Prevention Act.
-
February 10, 2026
Top PTAB Judges Save 2 Claims In Signify Lighting Patent
Three top Patent Trial and Appeal Board judges have reversed the board's invalidation of a pair of claims in a Signify Holdings BV lighting patent, saying the challengers to the patent improperly made new obviousness arguments in a reply brief.
-
February 10, 2026
'What I Like About You' Bandmates Seek End To Royalty Spat
The founding guitarist of The Romantics asked a federal judge to either appoint a receiver or dissolve the company that manages the "What I Like About You" performers' finances, as his bandmate argued it's time for a judge to put an end to "meritless" self-dealing accusations.
-
February 10, 2026
GSK, Teva Settle 'Skinny Label' Heart Medication Suit
GlaxoSmithKline and Teva told a Delaware federal judge that they've settled GSK's decade-long "skinny label" patent fight over heart failure medication and asked the court to end the case.
-
February 10, 2026
Lutnick Rules Out Creating Value-Based Fees For Patents
Commerce Secretary Howard Lutnick told a Senate panel Tuesday that the government is not planning to establish new fees for U.S. patents based on their value, saying the idea he was reportedly considering "is not going anywhere."
-
February 10, 2026
Lipid Testing Patents Recite Laws Of Nature, Judge Says
A Massachusetts federal judge has dismissed a company's infringement claims against a rival over patents that cover methods of testing for lysosomal storage disorders, ruling that the patents only cited patent-ineligible laws of nature.
-
February 10, 2026
Apple Again Pushes To Escape Masimo's $634M IP Verdict
Apple is doubling down on its bid to have U.S. District Judge James V. Selna relieve it from a jury's $634 million infringement verdict in litigation over its Apple Watch, saying Masimo Corp. relied on an improper and "shifting" definition of a dispositive term.
-
February 10, 2026
Voltage Infringing Shoals' Solar Patents, ITC Judge Rules
North Carolina-based Voltage LLC and a Chinese manufacturing company are infringing two patents on solar energy-related products held by Shoals Technologies Group, a U.S. International Trade Commission judge found.
-
February 10, 2026
Fed. Circ. Won't Save Co.'s Armor Panel IP Suit Against Rival
The Federal Circuit on Tuesday agreed with a Maryland federal court's decision that a company didn't infringe a bulletproof armor patent owned by a rival antiballistic panel manufacturer, finding the lower court took the correct approach to a key claim preamble.
-
February 10, 2026
Ex-Pro Basketball Player Denied Bid For College Hoops Return
Former NBA developmental league player Charles Bediako will not be able to keep competing for the University of Alabama after an Alabama state judge rejected his bid for an injunction overriding the NCAA's rules against professionals playing again in college.
-
February 10, 2026
2nd Circ. Revives Photographer's Case Against Shutterstock
The Second Circuit revived some of a landscape photographer's case against photo licensing database Shutterstock Inc. on Tuesday, finding that while there was nothing in evidence showing Shutterstock intended to change copyright management information, the company's "right and ability to control" the infringing activity should be litigated further.
-
February 10, 2026
Astellas Gets $90M From Lupin In Myrbetriq Patent Deal
Generic-drug maker Lupin Pharmaceuticals has inked a deal to pay $90 million to settle claims that it infringed patents held by rival Astellas Pharma Inc. covering name-brand bladder drug Myrbetriq.
-
February 10, 2026
Intellectual Property Group Of The Year: Gibson Dunn
Gibson Dunn & Crutcher LLP attorneys broke new ground in intellectual property matters last year, successfully defending Cisco in three big-dollar patent infringement cases and prevailing in a trademark dispute at the U.S. Supreme Court, earning the firm a place among the 2025 Law360 Intellectual Property Groups of the Year.
Expert Analysis
-
Evenflo IP Ruling Shows Evidence Is Still Key For Injunctions
Notwithstanding renewed policy and doctrinal attention to patent injunctions, the Federal Circuit's December decision in Wonderland v. Evenflo signals that the era of easily obtained patent injunctions has not yet arrived, say attorneys at King & Wood.
-
What US Cos. Must Know To Comply With Italy's AI Law
Italy's newly effective artificial intelligence law means U.S. companies operating in Italy or serving Italian customers must now meet EU AI Act obligations as well as Italy-specific requirements, including immediately enforceable criminal penalties, designated national authorities and sector-specific mandates, say attorneys at Portolano Cavallo.
-
Navigating Battery Validation Risk In The EV Supply Chain
Vehicle electrification has moved battery system supply chains from a background component into the center of the automotive universe — and for legal teams, battery validation is now a driver of contractual disputes, regulatory exposure and even shareholder litigation, say Samuel Madden at Secretariat Advisors and Vanessa Miller at Foley & Lardner.
-
Fed. Circ. In 2025: A Look At Continued USPTO Tensions
Unanticipated developments in 2025 included a tug-of-war between the Federal Circuit and the U.S. Patent and Trademark Office over inter partes review decisions, and this continued disparity looks set to contribute to another packed year for the court, say attorneys at Knobbe Martens.
-
How 2025 Recalibrated Fair Use For The AI Era
Although the Second Circuit's decision last year in Romanova v. Amilus Inc. did not involve artificial intelligence, its formulation of relevant fair use factors provides a useful guide for lower courts examining AI cases in 2026, demanding close attention from legal practitioners on both sides of these disputes, say attorneys at Cleary.
-
Series
Adapting To Private Practice: 5 Tips From Ex-SEC Unit Chief
My move to private practice has reaffirmed my belief in the value of adaptability, collaboration and strategic thinking — qualities that are essential not only for successful client outcomes, but also for sustained professional satisfaction, says Dabney O’Riordan at Fried Frank.
-
Patent Applicants Must Get Biologics Enablement Right
As artificial intelligence increasingly becomes a core driver in drug discovery, it is critical for drug companies to adapt their drafting strategies to the unique features of AI-generated inventions, and to pay particularly close attention to enablement standards, says Sanandan Malhotra at Novo Nordisk.
-
Series
Law School's Missed Lessons: How To Start A Law Firm
Launching and sustaining a law firm requires skills most law schools don't teach, but every lawyer should understand a few core principles that can make the leap calculated rather than reckless, says Sam Katz at Athlaw.
-
Fed. Circ. Patent Decisions In 2025: An Empirical Review
In 2025, the Federal Circuit's increased output was not enough to keep up with its ever-growing patent case load, and patent owners and applicants fared poorly overall as the court's affirmance rate fell, says Dan Bagatell at Perkins Coie.
-
Reel Justice: 'Die My Love' And The Power Of Visuals At Trial
The powerful use of imagery to capture the protagonist’s experience of postpartum depression in “Die My Love” reminds attorneys that visuals at trial can persuade jurors more than words alone, so they should strategically wield a new federal evidence rule allowing for illustrative aids, says Veronica Finkelstein at Wilmington University.
-
Series
Hosting Exchange Students Makes Me A Better Lawyer
Opening my home to foreign exchange students makes me a better lawyer not just because prioritizing visiting high schoolers forces me to hone my organization and time management skills but also because sharing the study-abroad experience with newcomers and locals reconnects me to my community, says Alison Lippa at Nicolaides Fink.
-
Utilizing AI In Agriculture Requires A Strong IP Strategy
As agricultural technology companies race to deploy artificial intelligence solutions at scale, it's important to prioritize the importance of intellectual property strategy early on to avoid losing value in a fast-moving landscape, say attorneys at Sterne Kessler.
-
How A 1947 Tugboat Ruling May Shape Work Product In AI Era
Rapid advances in generative artificial intelligence test work-product principles first articulated in the U.S. Supreme Court’s nearly 80-year-old Hickman v. Taylor decision, as courts and ethics bodies confront whether disclosure of attorneys’ AI prompts and outputs would reveal their thought processes, say Larry Silver and Sasha Burton at Langsam Stevens.
-
Lessons From The Pokemon Patent Firestorm
Public outcry against Nintendo being granted a patent over Pokémon gaming mechanics amid its ongoing patent infringement case against "Palworld" developer Pocket Pair, and the U.S. Patent and Trademark Office's subsequent order to reexamine Nintendo's patent, highlight potential risks associated with drafting ambiguous, unnecessarily complex or overly aggressive claims, say attorneys at McNees Wallace.
-
Navigating Privilege Law Patchwork In Dual-Purpose Comms
Three years after the U.S. Supreme Court declined to resolve a circuit split in In re: Grand Jury, federal courts remain split as to when attorney-client privilege applies to dual-purpose legal and business communications, and understanding the fragmented landscape is essential for managing risks, say attorneys at Covington.